Navigation Links
Caraco Pharmaceutical Laboratories, Ltd. Announces Extension and Future Termination of Distribution Agreements with Sun Pharma
Date:12/27/2010

the distribution agreements will have a material adverse effect on our operations.

Detroit-based Caraco Pharmaceutical Laboratories, Ltd., develops, manufactures, markets and distributes generic pharmaceuticals to the nation's largest wholesalers, distributors, drugstore chains and managed care providers.

Safe Harbor: This news release contains forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Without limitation, the words "believe" or "expect" and similar expressions are intended to identify forward-looking statements. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties are contained in the Corporation's filings with the Securities and Exchange Commission, including Part I, Item 1A of our most recent Form 10-K, and include but are not limited to: (i) that the information is of a preliminary nature and may be subject to further adjustment; (ii) not obtaining FDA approval for new products or delays in receiving FDA approvals; (iii) governmental restrictions on the sale of certain products; (iv) dependence on key personnel; (v) development by competitors of new or superior products or cheaper products or new technology for the production of products or the entry into the market of new competitors; (vi) market and customer acceptance and demand for new pharmaceutical products; (vii) availability of raw materials in a timely manner, at competitive prices, and in required quantities; (viii) timing and success of product development and launch; (ix) integrity and reliability of the Company's data; (x) lack of success in attaining full compliance with regard to regulatory and cGMP compliance; (xi) dependence on limited customer base; (xii) occasional credits to certain customers reflecting pri
'/>"/>

SOURCE Caraco Pharmaceutical Laboratories, Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Independent Committee of Caraco Board Retains Independent Advisors for Consideration of Sun Pharma Proposal to Purchase Outstanding Shares and Caraco Acknowledges Filing of Purported Class Action Lawsuits
2. Independent Committee of Caraco Board to Consider Sun Pharma Proposal to Purchase Outstanding Shares
3. Caraco Receives Sun Pharma Proposal to Purchase All Outstanding Shares
4. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2011
5. Caraco Pharmaceutical Laboratories, Ltd. Announces Change to Executive Team as G. P. Singh to Assume Position of CEO Effective November 1, 2010 and Update on Remediation Status
6. Caraco Pharmaceutical Laboratories, Ltd. Announces Appointment of Eddie Munson to Board of Directors
7. Caraco Pharmaceutical Laboratories, Ltd. Announces G.P. Singh Sachdeva Is Appointed as Chief Operating Officer
8. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Flomax®
9. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Wellbutrin SR® Extended Release Tablets
10. Caraco Pharmaceutical Laboratories, Ltd. Receives Notice Regarding NYSE Amex Continued Listing Standards
11. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Optivar®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... 2015  Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today ... Wells Fargo Securities 2015 Healthcare Conference in Boston ... th at 2:30 p.m. Eastern Time. To listen to ... visit the Investors section of the Company,s Web site at ... days after the event.  Orexigen Contact: , ...
(Date:9/4/2015)... , Sept. 4, 2015  Allergan plc (NYSE: ... Brent Saunders , CEO and President of Allergan, will ... the Morgan Stanley Global Healthcare Conference 2015 in ... http://photos.prnewswire.com/prnh/20150612/222796LOGO The presentation will take place ... at the Grand Hyatt New York, 109 East 42nd Street, ...
(Date:9/4/2015)... Research and Markets ( http://www.researchandmarkets.com/research/gvzjt8/investigation ) has announced ... Ibandronate Market, 2010-2019" report to their offering. ... name of Bondronat in Germany and ... approved by the FDA to come into the market as ... Boniva. However, since drug makers later developed more convenient dose, ...
Breaking Medicine Technology:Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 2Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 3Investigation Report on China's Sodium Ibandronate Market 2010-2019 2
... 3, 2011 Thoratec Corporation (NASDAQ: THOR ... therapies to save, support and restore failing hearts, said ... $111.2 million, a 17 percent increase over revenues of ... Results for all periods of fiscal 2010 exclude ...
... IRVINE, Calif., Aug. 3, 2011 Endologix, Inc. ... of minimally invasive treatments for aortic disorders, announced ... Officer, is scheduled to present at two upcoming ... the 31st Annual Canaccord Genuity Growth Conference in ...
Cached Medicine Technology:Thoratec Reports Second Quarter Revenue Increase of 17 Percent 2Thoratec Reports Second Quarter Revenue Increase of 17 Percent 3Thoratec Reports Second Quarter Revenue Increase of 17 Percent 4Thoratec Reports Second Quarter Revenue Increase of 17 Percent 5Thoratec Reports Second Quarter Revenue Increase of 17 Percent 6Thoratec Reports Second Quarter Revenue Increase of 17 Percent 7Thoratec Reports Second Quarter Revenue Increase of 17 Percent 8Thoratec Reports Second Quarter Revenue Increase of 17 Percent 9Thoratec Reports Second Quarter Revenue Increase of 17 Percent 10Thoratec Reports Second Quarter Revenue Increase of 17 Percent 11Thoratec Reports Second Quarter Revenue Increase of 17 Percent 12Thoratec Reports Second Quarter Revenue Increase of 17 Percent 13Thoratec Reports Second Quarter Revenue Increase of 17 Percent 14Thoratec Reports Second Quarter Revenue Increase of 17 Percent 15Thoratec Reports Second Quarter Revenue Increase of 17 Percent 16Thoratec Reports Second Quarter Revenue Increase of 17 Percent 17Thoratec Reports Second Quarter Revenue Increase of 17 Percent 18Thoratec Reports Second Quarter Revenue Increase of 17 Percent 19Endologix to Present at Two Upcoming Conferences 2
(Date:9/4/2015)... ... 2015 , ... A Union County charitable organization will host ... is a non-profit organization dedicated to offering Pilates scholarships to cancer patients to ... recover their mobility, strength, and range of motion following breast cancer surgery. ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... CEREC technology is now available at CitiDent. CEREC is a newer method for ... to saving time for patients by eliminating the need for multiple appointments, CEREC ...
(Date:9/4/2015)... , ... September 04, 2015 , ... Many consumers are looking for a quick and ... their solution. , The patent-pending K Med Cups provide a quick and simple way to ... relieve a cold, flu or cough. As a result, they enhance comfort and health. The ...
(Date:9/4/2015)... ME (PRWEB) , ... September 04, 2015 , ... ... focus on: the microbiome taking place in Hollywood, Florida October 9-10, 2015 at ... , Speakers at the 2015 symposium are doctors and researchers at the top ...
(Date:9/4/2015)... ... , ... Lalonde Gordon ran a 44.64 seconds scorcher in the third and ... 400 meters final, with an impressive 44.89 seconds at the 2015 North American, Central ... in August 2015. The 44.64 time is a new NACAC Championship record. , ...
Breaking Medicine News(10 mins):Health News:Girl’s Night Out to Benefit Core Compassion Project, Located at the Beautiful, Morning Glory Farm 2Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3
... University of Minnesota,s College of Liberal Arts and College of ... the brain,s visual system rewires itself when people are trained ... that this neural learning appears to be independent of higher ... shape training programs for people who must learn to detect ...
... promotional drinking glasses, and other children,s products constitute an ... ingredients in these products and other changes in policy ... in ACS, Environmental Science & Technology , a ... Rachel Massey note that in June the United States ...
... HealthDay Reporter , WEDNESDAY, Nov. 10 (HealthDay News) -- ... increase the risk of cancer and may even decrease users, ... finds. Studies have shown that the short-term use of ... has little effect on the risk of developing cancer, but ...
... at a large university and to change the drinking culture ... of an Indiana University study. Freshmen living on ... consumed in a week; in the percentage who drank at ... the proportion of students who engaged in binge drinking in ...
... HealthDay Reporter , TUESDAY, Nov. 9 (HealthDay News) ... the lower her odds for developing invasive breast cancers, according ... the American Association of Cancer Research in Philadelphia. That ... meeting found that hormone replacement therapy might raise women,s odds ...
... A hormone already responsible for increasing blood pressure ... moonlight as a major stimulator of the brain centers ... Researchers at UT Southwestern Medical Center studied patients who ... effect on sympathetic nerve activity responsible for blood pressure ...
Cached Medicine News:Health News:U of M researchers find learning in the visual brain 2Health News:Long-Term Statin Use Won't Raise Cancer Risk: Study 2Health News:APHA 2010: Attacking the drinking culture on college campuses from different directions 2Health News:Soy Chemicals May Lower Risk for Invasive Breast Cancer 2Health News:Soy Chemicals May Lower Risk for Invasive Breast Cancer 3Health News:Researchers discover important link between adrenal gland hormone and brain in hypertension 2
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
... System - the first family of instruments ... System has been methodically designed to give ... Beaver safety knives have an integrated ... protects healthcare workers from sharps injury, and ...
The Escape Basket offers a side-by-side approach, unique to the market, for using a nitinol basket and holmium laser fiber together-providing physician control and independent manipulation of both th...
Medicine Products: